The import of pharmaceutical goods to Vietnam has shown a consistent upward trend, with values predicted to rise from $108.81 million in 2024 to $124.74 million by 2028. The actual import value for 2023 stood at $104.92 million. Year-on-year variations depict a steady growth: 3.8% from 2024 to 2025, 3.6% from 2025 to 2026, 3.4% from 2026 to 2027, and 3.2% from 2027 to 2028. Over the last two years, the average annual compound growth rate (CAGR) reflects an approximate increase of 3.6% per year from 2023 to 2028.
Future trends to watch for include advancements in local manufacturing capabilities, changes in trade policies affecting import tariffs, and the impact of international trade agreements. Monitoring the evolution of healthcare demands and regulatory changes will be crucial in predicting future market dynamics. Furthermore, shifts in global pharmaceutical supply chains could also influence import patterns significantly.
